Current issue
Archive
About the journal
Editorial board
Abstracting and indexing
Subscription
Contact
Instructions for authors
Publication charge
Ethical standards and procedures
Editorial System
Submit your Manuscript
|
3/2016
vol. 97 abstract:
REVIEW PAPER
Cell-based assays in high-throughput mode (HTS)
Kalyani Rajalingham
1
vol. 97(3) C pp. 227-234 C 2016
Online publish date: 2016/11/02
View
full text
Get citation
ENW EndNote
BIB JabRef, Mendeley
RIS Papers, Reference Manager, RefWorks, Zotero
AMA
APA
Chicago
Harvard
MLA
Vancouver
Typically, novel compounds are screened by the millions, a process known as high-throughput screening (HTS). HTS allows for the screening of millions of potential drugs in a relatively short period of time. All compounds are initially subjected to various tests to determine safety and efficacy. At the molecular level, typically two types of tests are available: in vitro and cell-based assays (i.e., in vivo ). The distinction between a cell-based assay and an in vitro screening is that the cell-based assay utilizes live cells – approximately 50 000 cells are seeded onto the floor of the well. Cell-based assays are used to measure proliferation, toxicity, marker production, motility, activation of signaling pathways, and changes in morphology. In such cases, other factors such as 2D versus 3D culture or static versus profusion cultures might also contribute to the results obtained. This study emphasizes the positive aspects of using cell-based assays in high-throughput mode.
keywords:
cell-based assay, high-throughput screening, drug discovery |